Metropolitan Life Insurance Company (MetLife)’s Leidos LDOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,545
| Closed | -$727K | – | 1163 |
|
|
2024
Q1 | $727K | Sell |
5,545
-52
| -0.9% | -$6.2K | 0.03% | 397 |
|
|
2023
Q4 | $606K | Sell |
5,597
-84
| -1% | -$8.56K | 0.03% | 432 |
|
|
2023
Q3 | $524K | Sell |
5,681
-296
| -5% | -$27.9K | 0.03% | 436 |
|
|
2023
Q2 | $529K | Sell |
5,977
-136
| -2% | -$11.6K | 0.03% | 446 |
|
|
2023
Q1 | $563K | Sell |
6,113
-1,584
| -21% | -$153K | 0.03% | 439 |
|
|
2022
Q4 | $810K | Sell |
7,697
-429
| -5% | -$43.9K | 0.04% | 411 |
|
|
2022
Q3 | $711K | Sell |
8,126
-103
| -1% | -$10.1K | 0.03% | 427 |
|
|
2022
Q2 | $829K | Sell |
8,229
-431
| -5% | -$44.7K | 0.04% | 413 |
|
|
2022
Q1 | $935K | Sell |
8,660
-7,395
| -46% | -$713K | 0.03% | 432 |
|
|
2021
Q4 | $1.43M | Sell |
16,055
-585
| -4% | -$54.8K | 0.02% | 717 |
|
|
2021
Q3 | $1.6M | Buy |
16,640
+306
| +2% | +$30.3K | 0.02% | 633 |
|
|
2021
Q2 | $1.65M | Sell |
16,334
-845
| -5% | -$86.8K | 0.02% | 645 |
|
|
2021
Q1 | $1.65M | Sell |
17,179
-910
| -5% | -$92K | 0.02% | 619 |
|
|
2020
Q4 | $1.9M | Sell |
18,089
-717
| -4% | -$68.7K | 0.03% | 503 |
|
|
2020
Q3 | $1.68M | Sell |
18,806
-810
| -4% | -$73.2K | 0.03% | 483 |
|
|
2020
Q2 | $1.84M | Sell |
19,616
-337
| -2% | -$33.2K | 0.03% | 435 |
|
|
2020
Q1 | $1.83M | Sell |
19,953
-77
| -0.4% | -$7.77K | 0.04% | 420 |
|
|
2019
Q4 | $1.96M | Sell |
20,030
-85
| -0.4% | -$7.49K | 0.03% | 560 |
|
|
2019
Q3 | $1.73M | Sell |
20,115
-21,042
| -51% | -$1.76M | 0.03% | 569 |
|
|
2019
Q2 | $3.29M | Sell |
41,157
-499
| -1% | -$36.4K | 0.06% | 302 |
|
|
2019
Q1 | $2.67M | Sell |
41,656
-1,006
| -2% | -$60.7K | 0.05% | 338 |
|
|
2018
Q4 | $2.25M | Sell |
42,662
-104
| -0.2% | -$6.46K | 0.05% | 364 |
|
|
2018
Q3 | $2.96M | Buy |
42,766
+1,608
| +4% | +$109K | 0.05% | 324 |
|
|
2018
Q2 | $2.43M | Buy |
41,158
+78
| +0.2% | +$4.86K | 0.04% | 419 |
|
|
2018
Q1 | $2.69M | Buy |
41,080
+347
| +0.9% | +$22.9K | 0.04% | 370 |
|
|
2017
Q4 | $2.63M | Sell |
40,733
-92,988
| -70% | -$5.83M | 0.03% | 382 |
|
|
2017
Q3 | $7.92M | Sell |
133,721
-1,288
| -1% | -$71.7K | 0.05% | 334 |
|
|
2017
Q2 | $6.98M | Sell |
135,009
-460
| -0.3% | -$24.5K | 0.05% | 377 |
|
|
2017
Q1 | $6.93M | Sell |
135,469
-354
| -0.3% | -$18.2K | 0.05% | 395 |
|
|
2016
Q4 | $6.95M | Sell |
135,823
-31
| -0% | -$1.45K | 0.05% | 381 |
|
|
2016
Q3 | $5.88M | Buy |
135,854
+75,075
| +124% | +$3.41M | 0.04% | 445 |
|
|
2016
Q2 | $2.91M | Buy |
60,779
+2,234
| +4% | +$110K | 0.02% | 784 |
|
|
2016
Q1 | $2.95M | Buy |
58,545
+1,701
| +3% | +$81.1K | 0.02% | 757 |
|
|
2015
Q4 | $3.2M | Buy |
56,844
+267
| +0.5% | +$14.1K | 0.02% | 703 |
|
|
2015
Q3 | $2.34M | Buy |
56,577
+917
| +2% | +$38.3K | 0.02% | 851 |
|
|
2015
Q2 | $2.25M | Buy |
55,660
+749
| +1% | +$31.5K | 0.02% | 924 |
|
|
2015
Q1 | $2.3M | Buy |
54,911
+1,900
| +4% | +$82.6K | 0.02% | 851 |
|
|
2014
Q4 | $2.31M | Buy |
53,011
+481
| +0.9% | +$18.8K | 0.02% | 922 |
|
|
2014
Q3 | $1.8M | Sell |
52,530
-704
| -1% | -$26K | 0.01% | 986 |
|
|
2014
Q2 | $2.04M | Sell |
53,234
-7,555
| -12% | -$286K | 0.01% | 996 |
|
|
2014
Q1 | $2.15M | Buy |
60,789
+1,118
| +2% | +$49.7K | 0.01% | 953 |
|
|
2013
Q4 | $2.77M | Buy |
59,671
+242
| +0.4% | +$11.2K | 0.02% | 799 |
|
|
2013
Q3 | $953K | Sell |
59,429
-13,834
| -19% | -$514K | 0.01% | 1308 |
|
|
2013
Q2 | $2.52M | Buy |
+73,263
| New | +$2.6M | 0.02% | 762 |
|
Other funds holding LDOS
Metropolitan Life Insurance Company (MetLife)'s LDOS Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Leidos (LDOS) in Q2 2024, closing a stake of 5,545 shares — an estimated $727K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in LDOS in Q2 2013 and held it in 44 quarters. The position peaked at $7.92M in Q3 2017. 737 funds tracked by Wall St. Rank hold LDOS as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Leidos position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 5,545 Leidos shares in Q2 2024, an estimated $727K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Leidos in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Leidos position peaked at $7.92M in Q3 2017.
- 737 funds tracked by Wall St. Rank held Leidos as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.